CR · Company research

Crane Company (CR): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

26records availableBasic Materials

Stock News & Events data

Database-backed records only

26 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Illinois Tool Works (ITW) Earnings Expected to Grow: Should You Buy?Illinois Tool Works is expected to report Q3 2026 earnings of $2.99 per share with revenues of $4.26 billion, representing year-over-year growth. However, recent analyst estimate revisions have turned slightly bearish, with a negative Earnings ESP of -0.52% and a Zacks Rank #3 (Hold), making it difficult to predict an earnings beat. The company has historically beaten estimates in the last four quarters.View source ↗Zacks Investment ResearchOct 20, 2026bullish0.51
P.C. GENERAL DE ALIMENTOS NISA, (GE266.CR) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance CanadaP.C. GENERAL DE ALIMENTOS NISA, (GE266.CR) Interactive Stock Chart - Yahoo Finance Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 16, 2026neutral00.6
P.C. GENERAL DE ALIMENTOS NISA, (GE266.CR) stock price, news, quote and history - Yahoo Finance AustraliaP.C. GENERAL DE ALIMENTOS NISA, (GE266.CR) stock price, news, quote and history Yahoo Finance AustraliaView source ↗Yahoo Finance AustraliaOct 16, 2026neutral00.6
FDA seizes 359 tonnes of food stock worth Rs 9.63 cr across Ngp division - The HitavadaFDA seizes 359 tonnes of food stock worth Rs 9.63 cr across Ngp division The HitavadaView source ↗The HitavadaOct 16, 2026neutral00.6
Goldman Sachs Sells Eternal Shares Via A ₹169 Cr Block Deal - Inc42Goldman Sachs Sells Eternal Shares Via A ₹169 Cr Block Deal Inc42View source ↗Inc42Oct 15, 2026neutral00.6
Why (CR) Price Action Is Critical for Tactical Trading - Stock Traders DailyWhy (CR) Price Action Is Critical for Tactical Trading Stock Traders DailyView source ↗Stock Traders DailyOct 15, 2026neutral00.6
More than 125 patients have received an experimental cancer drug. It’s now being tested with chemotherapy. - Stock TitanMore than 125 patients have received an experimental cancer drug. It’s now being tested with chemotherapy. Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
Crane (NYSE:CR) Stock Price Breaks Above 200 Day Moving Average - Here's Why - MarketBeatCrane (NYSE:CR) Stock Price Breaks Above 200 Day Moving Average - Here's Why MarketBeatView source ↗MarketBeatOct 15, 2026neutral00.6
Here’s How Much You Would Have Made Owning Crane Stock In The Last 5 Years - BenzingaHere’s How Much You Would Have Made Owning Crane Stock In The Last 5 Years BenzingaView source ↗BenzingaOct 14, 2026neutral00.6
Here's Why It is Appropriate to Invest in Emerson Right NowEmerson Electric (EMR) demonstrates strong growth momentum with 6% underlying sales increase and 7% order growth in Q3 fiscal 2026. The company's strategic acquisitions of Glue Inc. and full ownership of AspenTech expand its software and automation capabilities. Strong free cash flow of $2.62 billion supports shareholder returns through dividends and share buybacks, with a recent 5% dividend increase.View source ↗Zacks Investment ResearchOct 14, 2026bullish0.751
Here's Why It is Appropriate to Invest in Emerson Right NowEmerson Electric (EMR) demonstrates strong growth momentum with 6% underlying sales increase and 7% order growth in Q3 fiscal 2026. The company's strategic acquisitions of Glue Inc. and full ownership of AspenTech expand its software and automation capabilities. Strong free cash flow of $2.62 billion supports shareholder returns through dividends and share buybacks, with a recent 5% dividend increase.View source ↗Zacks Investment ResearchOct 14, 2026bullish0.751
Weekly Recap: Board-approved Rs17,500–18,000cr raise and Q2 AUM ₹5.85tn growth - TradingViewWeekly Recap: Board-approved Rs17,500–18,000cr raise and Q2 AUM ₹5.85tn growth TradingViewView source ↗TradingViewOct 12, 2026neutral00.6
iShs V-iBds Dec 2028 Term DL CR (CBU5.MU) Stock Price, News, Quote & History - Yahoo! Finance CanadaiShs V-iBds Dec 2028 Term DL CR (CBU5.MU) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 11, 2026neutral00.6
Peak XV Partners Sells Awfis Shares Worth Rs 29.8 Cr In Bulk Deal - BW DisruptPeak XV Partners Sells Awfis Shares Worth Rs 29.8 Cr In Bulk Deal BW DisruptView source ↗BW DisruptOct 10, 2026neutral00.6
iShs V-iBds Dec 2028 Term DL CR (CBU5.MU) Latest Stock News & Headlines - Yahoo! Finance CanadaiShs V-iBds Dec 2028 Term DL CR (CBU5.MU) Latest Stock News & Headlines Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 9, 2026neutral00.6
P.C. GENERAL DE ALIMENTOS NISA, (GE269P.CR) stock price, news, quote and history - Yahoo Finance UKP.C. GENERAL DE ALIMENTOS NISA, (GE269P.CR) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKOct 8, 2026neutral00.6
P.C. GENERAL DE ALIMENTOS NISA, (GE269P.CR) stock historical prices and data - Yahoo Finance UKP.C. GENERAL DE ALIMENTOS NISA, (GE269P.CR) stock historical prices and data Yahoo Finance UKView source ↗Yahoo Finance UKOct 8, 2026neutral00.6
P.C. GENERAL DE ALIMENTOS NISA, (GE269P.CR) stock major holders - Yahoo Finance UKP.C. GENERAL DE ALIMENTOS NISA, (GE269P.CR) stock major holders Yahoo Finance UKView source ↗Yahoo Finance UKOct 8, 2026neutral00.6
7,098 Crane $CR Shares Bought by Venture Visionary Partners LLC - MarketBeat7,098 Crane $CR Shares Bought by Venture Visionary Partners LLC MarketBeatView source ↗MarketBeatOct 8, 2026neutral00.6
Crane $CR Stock Sold by Congress Asset Management Co. - MarketBeatCrane $CR Stock Sold by Congress Asset Management Co. MarketBeatView source ↗MarketBeatOct 6, 2026neutral00.6
The FDA clears an application to test Crescent’s cancer treatment in people. - Stock TitanThe FDA clears an application to test Crescent’s cancer treatment in people. Stock TitanView source ↗Stock TitanOct 5, 2026neutral00.6
Crane (NYSE:CR) Stock Sold Off by Rep. Kevin Hern - MarketBeatCrane (NYSE:CR) Stock Sold Off by Rep. Kevin Hern MarketBeatView source ↗MarketBeatSep 29, 2026neutral00.6
Will Raised EPS Guidance Change Crane (CR) Stock Narrative - Simply Wall StreetWill Raised EPS Guidance Change Crane (CR) Stock Narrative Simply Wall StreetView source ↗Simply Wall StreetSep 25, 2026neutral00.6
Crane (CR) Stock May Be Near Fair Value After $240 Million Pump Deal - Yahoo FinanceCrane (CR) Stock May Be Near Fair Value After $240 Million Pump Deal Yahoo FinanceView source ↗Yahoo FinanceSep 14, 2026neutral00.6
Crane (CR) Stock Sinks As Record Margins Meet Rich Valuation - Simply Wall StreetCrane (CR) Stock Sinks As Record Margins Meet Rich Valuation Simply Wall StreetView source ↗Simply Wall StreetJul 29, 2026neutral00.6
Crane Company (CR) Stock Rises on Q1 2026 Earnings - Quiver QuantitativeCrane Company (CR) Stock Rises on Q1 2026 Earnings Quiver QuantitativeView source ↗Quiver QuantitativeApr 27, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.